Both in Biotechnology
Vericel vs ADMA Biologics
Over the past year VCEL returned +10.4% and ADMA returned −28.0%; their daily moves had a correlation of 0.22.
VCEL +10.4% ADMA −28.0%Growth of $1, one year, split-adjusted
| Metric | VCEL | ADMA |
|---|---|---|
| Price | $40.51 | $11.06 |
| Market cap | $2.07B | $2.48B |
| Today | +0.62% | −3.07% |
| 1 month | +0.9% | +13.8% |
| 6 months | +11.0% | +7.3% |
| Year to date | +12.5% | −39.4% |
| 1 year | +17.3% | −27.6% |
| Revenue growth (YoY) | +22.5% | +2.0% |
| Gross margin | 72.8% | 69.4% |
| Net margin | 2.8% | 30.4% |
| P/E (TTM) | 85.6× | 14.7× |
| Price / sales | 6.8× | 4.8× |
| Net cash | $162.5M | -$60.6M |
| Dividend yield | — | — |
| Volatility (60d) | 33.0% | 38.6% |
| Short % of float | 11.1% | 9.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).